- patient currently hospitalized or under immediate consideration for hospitalization; - patient currently in shock or with hemodynamic instability; - patient undergoing chemotherapy for cancer; - patient is unable to take oral temperature using an electronic thermometer; - patient who received at least one dose of the covid-19 vaccine; - female patient who is pregnant or breast-feeding or is considering becoming pregnant during the study; - people taking anticoagulant/antiplatelet medications, those with bleeding disorders, and people two weeks before or after surgery; - patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study; - regular consumption of natural products containing more than 150 mg of hesperidin or regular consumption of more than 1 glass of orange juice per day; - known allergy to any of the medicinal and non-medicinal ingredient: hesperidin, microcrystalline cellulose, magnesium stearate.

- patient currently hospitalized or under immediate consideration for hospitalization; - patient currently in shock or with hemodynamic instability; - patient undergoing chemotherapy for cancer; - patient is unable to take oral temperature using an electronic thermometer; - patient who received at least one dose of the covid-19 vaccine; - female patient who is pregnant or breast-feeding or is considering becoming pregnant during the study; - people taking anticoagulant/antiplatelet medications, those with bleeding disorders, and people two weeks before or after surgery; - patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study; - regular consumption of natural products containing more than 150 mg of hesperidin or regular consumption of more than 1 glass of orange juice per day; - known allergy to any of the medicinal and non-medicinal ingredient: hesperidin, microcrystalline cellulose, magnesium stearate.

- patient currently hospitalized or under immediate consideration for hospitalization - patient currently in shock or with hemodynamic instability; - patient undergoing chemotherapy for cancer; - patient is unable to take oral temperature using an electronic thermometer; - female patient who is pregnant or breast-feeding or is considering becoming pregnant during the study; - people taking anticoagulant/antiplatelet medications, those with bleeding disorders, and people two weeks before or after surgery; - patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study; - regular consumption of natural products containing more than 150 mg of hesperidin or regular consumption of more than 1 glass of orange juice per day; - known allergy to any of the medicinal and non-medicinal ingredient: hesperidin, microcrystalline cellulose, magnesium stearate.

- patient currently hospitalized or under immediate consideration for hospitalization - patient currently in shock or with hemodynamic instability; - patient undergoing chemotherapy for cancer; - patient is unable to take oral temperature using an electronic thermometer; - female patient who is pregnant or breast-feeding or is considering becoming pregnant during the study; - people taking anticoagulant/antiplatelet medications, those with bleeding disorders, and people two weeks before or after surgery; - patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study; - regular consumption of natural products containing more than 150 mg of hesperidin or regular consumption of more than 1 glass of orange juice per day; - known allergy to any of the medicinal and non-medicinal ingredient: hesperidin, microcrystalline cellulose, magnesium stearate.